LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Transave Inc.
Headquarters:
Monmouth Junction, NJ, United States of America
Website:
N/A
Year Founded:
1997
Status:
Acquired
BioCentury
|
Feb 4, 2020
Product Development
Insmed planning Phase III for rare lung disorder therapy following mixed Phase II readout
Read More
BioCentury
|
Aug 11, 2014
Clinical News
Arikace amikacin regulatory update
Read More
BioCentury
|
Jun 23, 2014
Clinical News
Amikacin regulatory update
Read More
BioCentury
|
Mar 31, 2014
Clinical News
Arikayce amikacin: Phase II data
Read More
BioCentury
|
Mar 27, 2014
Clinical News
Insmed falls on Arikayce miss for non-TB lung infection
Read More
BioCentury
|
Mar 3, 2014
Clinical News
Arikace amikacin: Extension study data
Read More
BioCentury
|
Oct 21, 2013
Clinical News
Arikace amikacin: Completed Phase II enrollment
Read More
BioCentury
|
Jul 16, 2013
Top Story
Insmed proposes $60M follow-on
Read More
BioCentury
|
Jul 15, 2013
Clinical News
Arikace: Phase III data
Read More
BioCentury
|
Jul 2, 2013
Clinical News
Insmed falls on Phase III data for lung infection compound
Read More
Items per page:
10
1 - 10 of 38
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help